Discovery of Chiral Cyclopropyl Dihydro-Alkylthio-Benzyl-Oxopyrimidine (<i>S</i>-DABO) Derivatives as Potent HIV-1 Reverse Transcriptase Inhibitors with High Activity Against Clinically Relevant Mutants

Marco Radi(University of Siena), Maurizio Botta(University of Siena), Alberta Samuele(Istituto di Genetica Molecolare), Lucilla Angeli(University of Siena), Andrea Tafi(University of Siena), Gianluca Giorgi(University of Siena), José A. Esté(Universitat Autònoma de Barcelona), Luca Bellucci(University of Siena), Maddalena Alongi(University of Siena), Eric Ennifar(University of Siena), Guillaume Bec(University of Siena), Giovanni Maga(National Research Council), Mireille Baltzinger(University of Siena), Gianni Casaluce(University of Siena), Emmanuel González(Inserm), Mercedes Armand‐Ugón(University of Siena), Philippe Dumas(University of Siena), Samantha Zanoli(Istituto di Genetica Molecolare)
Journal of Medicinal Chemistry
January 13, 2009
10.1021/jm801330n
Cited by 38

Related Papers

Proliferating cell nuclear antigen (PCNA): a dancer with many partners
|Journal of Cell Science|2003|1.1k
Altered microbiome composition in individuals with fibromyalgia
|Pain|2019|218
Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines
|Gut|2022|113
Toward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation
|ChemMedChem|2011|105
Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral Agent
|Journal of Medicinal Chemistry|2001|94